Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, keeping weight off after Wegovy is possible — but it takes deliberate effort, because the medicine does not permanently reset your appetite biology. Most people who stop semaglutide without putting habits in place regain a significant portion of lost weight within a year. That is not a failure of willpower; it reflects how the medicine works and why the approach to stopping matters as much as the treatment itself. Wegovy is a prescription-only weight-management injection, and any plan around continuing, pausing or stopping it should be made with a prescriber who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by activating GLP-1 receptors in the brain and gut, reducing appetite and slowing gastric emptying. While you are taking it, those effects are continuous. Stop the injections, and within weeks the drug clears and those signals fade. Hunger returns to something closer to where it was before treatment, and if eating habits have not meaningfully changed, calorie intake tends to drift back up.
The STEP 1 extension trial followed participants for a further 52 weeks after they stopped semaglutide 2.4mg. On average, people regained about two-thirds of the weight they had lost during the treatment phase. You can read the STEP 1 trial published in the New England Journal of Medicine for the full data. That is a striking figure, and it is honest, but it is also an average, and averages include people who regained almost nothing alongside people who regained everything. Outcome varies significantly depending on what someone does during and after treatment.
The biology is not a verdict. It is a reason to plan. People who use the treatment period to genuinely rebuild eating patterns, rather than simply eating less while the medicine suppresses appetite, tend to do considerably better after stopping. The medicine creates a window; habits are what you build inside it.
The honest answer is that no single behaviour guarantees sustained weight maintenance, but several factors consistently appear in the evidence. Regular physical activity (particularly strength training alongside cardio) helps preserve lean muscle mass lost during rapid weight loss and raises resting metabolic rate, making it easier to maintain a lower weight without severe calorie restriction.
Protein intake matters more than most people expect. Adequate protein supports satiety signals even after semaglutide has stopped, and it slows the muscle loss that accompanies weight reduction. NHS guidance on healthy weight emphasises a diet built around whole foods, fibre and balanced macronutrients rather than short-term restriction.
Behavioural consistency (regular meals, not skipping, not returning to the habits that drove weight gain originally) is perhaps the most important factor, and also the hardest to sustain without support. Joining a structured follow-up programme or working with a dietitian after stopping gives people accountability that the medicine itself provided passively. For more on practical strategies for maintaining results, that resource covers the lifestyle side in detail.
Sleep quality and stress management also affect hunger hormones independently of medication, which is worth taking seriously once Wegovy is no longer doing that work.
For many people, the answer is yes. NICE's appraisal of semaglutide (TA875) recommends it for a maximum of two years within specialist weight management services on the NHS, but private prescribing is not bound by the same two-year ceiling, it is governed by ongoing clinical assessment of benefit, tolerability and the individual's circumstances.
Some people remain on a 2.4mg maintenance dose indefinitely. Others find that a lower dose provides enough appetite modulation to prevent regain without the same cost or commitment. The question of how long semaglutide treatment can run is one our prescribers are asked regularly, and the answer is genuinely individual. There is no universal stopping point; the right time to stop, and the right plan for what comes after, emerges from a conversation with a clinician who knows your history.
If you are mid-treatment and wondering how the timeline of weight loss maps onto long-term planning, how long Wegovy takes to work gives useful context on what different phases of treatment typically look like. Wegovy is sometimes accessed via a regulated online pharmacy, worth understanding what that process involves if you are considering continuing treatment privately.
Regain after stopping is common. It does not mean treatment failed or that there is nothing to be done. Restarting semaglutide is clinically possible and, for many people, an entirely reasonable decision, subject to the same prescriber assessment required the first time. The dose titration schedule would typically start again from the beginning to manage tolerability.
The key thing to avoid is prolonged inaction. A modest, early regain is much easier to address than a full return to the starting point. If you stopped because of side effects, a different medicine or a lower tolerated dose may be worth discussing. If you stopped because treatment felt complete and weight has since crept back, returning to clinical support sooner rather than later tends to produce better outcomes.
The evidence on stopping Wegovy and what typically follows is covered in depth on that page. And if you are weighing up whether to restart or try a different route, our weight loss treatment overview sets out the options currently available. Check your eligibility for a free consultation with our prescribers at nume's treatment page. That consultation is reviewed the same day by a real clinician, not automated software, and every repeat prescription goes through the same clinical review, whether it is your first or your fifteenth.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.